05:16 PM EDT, 07/16/2024 (MT Newswires) -- Mark A Goldsmith, Director, President and Chief Executive Officer, on July 12, 2024, sold 35,000 shares in Revolution Medicines ( RVMD ) for $1,576,322. Following the Form 4 filing with the SEC, Goldsmith has control over a total of 802,913 shares of the company, with 311,885 shares held directly and 491,028 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1628171/000161071724000396/xslF345X03/form4.xml